Community Acquired Sphingomonas paucimobilis: Instigator or an Innocent Bystander

Indian J Med Microbiol. 2024 Mar-Apr:48:100524. doi: 10.1016/j.ijmmb.2023.100524. Epub 2024 Jan 3.

Abstract

Sphingomonas paucimobilis is a rare cause of bacteremia. It can affect both healthy and immunocompromised individuals. Community acquired infections of this organism are more common than nosocomial ones. We report two cases of community acquired S. paucimobilis bacteremia-one in a healthy patient and other in a diabetic patient. Both presented with multiple episodes of loose stools, pain abdomen, vomiting, decreased oral intake and myalgia. They responded well to Cefipime 1g and Sulbactam 500mg combination antibiotic and were discharged satisfactorily. In the absence of standardized guidelines, antibiotic sensitivity guided case-to-case therapy is warranted with prompt initiation to prevent complications.

Keywords: Bacteremia; Community acquired; Sphingomonas paucimobilis.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteremia* / diagnosis
  • Bacteremia* / drug therapy
  • Bacteremia* / microbiology
  • Community-Acquired Infections* / diagnosis
  • Community-Acquired Infections* / drug therapy
  • Community-Acquired Infections* / microbiology
  • Diabetes Complications / microbiology
  • Female
  • Gram-Negative Bacterial Infections* / diagnosis
  • Gram-Negative Bacterial Infections* / drug therapy
  • Gram-Negative Bacterial Infections* / microbiology
  • Humans
  • Male
  • Middle Aged
  • Sphingomonas* / isolation & purification
  • Sulbactam / therapeutic use
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Sulbactam